CSPC Pharmaceutical Group Limited (HKG:1093)
8.55
+0.18 (2.15%)
Jul 24, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Market Cap
CSPC Pharmaceutical Group has a market cap or net worth of 97.75 billion as of July 24, 2026. Its market cap has decreased by -0.11% in one year.
Market Cap
97.75B
Enterprise Value
88.25B
Revenue
28.94B
Ranking
n/a
PE Ratio
26.30
Stock Price
8.55
ChartMarket Cap Chart
Since December 4, 1995, CSPC Pharmaceutical Group's market cap has increased from 696.00M to 97.75B, an increase of 13,944.91%. That is a compound annual growth rate of 17.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 97.75B | 1.42% |
| Dec 31, 2025 | 96.38B | 74.70% |
| Dec 31, 2024 | 55.17B | -35.87% |
| Dec 29, 2023 | 86.02B | -11.96% |
| Dec 30, 2022 | 97.71B | -3.19% |
| Dec 31, 2021 | 100.93B | 6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 278.86B |
| Hansoh Pharmaceutical Group Company | 197.53B |
| WuXi Biologics | 159.39B |
| Innovent Biologics | 158.51B |
| Sichuan Kelun-Biotech Biopharmaceutical | 124.65B |
| JD Health International | 120.18B |
| Sino Biopharmaceutical | 95.26B |
| Akeso | 91.10B |